TRATAMIENTO DE LA GOTA AGUDA
暂无分享,去创建一个
A. DanielG.Fernández | P. JohnLondoño | M. PedroSantos | S. ElsaReyes | O. RafaelValle | P. JohnLondoño | S. ElsaReyes | A. DanielG.Fernández | M. PedroSantos | O. RafaelValle
[1] J. Levin,et al. Ketoprofen versus indomethacin in patients with acute gouty arthritis: a multicenter, double blind comparative study. , 1988, The Journal of rheumatology.
[2] R. Wortmann. Recent advances in the management of gout and hyperuricemia , 2005, Current opinion in rheumatology.
[3] T. Mikuls,et al. Understanding treatments for gout. , 2005, The American journal of managed care.
[4] Hyon K. Choi. Diet, alcohol, and gout: How do we advise patients given recent developments? , 2005, Current rheumatology reports.
[5] Hyon K. Choi,et al. Intake of purine-rich foods, protein, and dairy products and relationship to serum levels of uric acid: the Third National Health and Nutrition Examination Survey. , 2005, Arthritis and rheumatism.
[6] G. Nuki. Treatment of crystal arthropathy--history and advances. , 2006, Rheumatic diseases clinics of North America.
[7] Hyon K. Choi,et al. Coffee, tea, and caffeine consumption and serum uric acid level: the third national health and nutrition examination survey. , 2007, Arthritis and rheumatism.
[8] C. Siva,et al. Diagnosing acute monoarthritis in adults: a practical approach for the family physician. , 2003, American family physician.
[9] H. Schumacher,et al. Newer therapeutic approaches: gout. , 2006, Rheumatic diseases clinics of North America.
[10] J. MacKenzie,et al. Imaging features of crystal-induced arthropathy. , 2006, Rheumatic diseases clinics of North America.
[11] F. Lioté,et al. Gout: update on some pathogenic and clinical aspects. , 2006, Rheumatic diseases clinics of North America.
[12] R. Flores,et al. Acute monarthritis: diagnosis and management. , 2006, Primary care.
[13] G. Varughese,et al. Colchicine in acute gout , 2003, BMJ : British Medical Journal.
[14] A. Eggebeen. Gout: an update. , 2007, American family physician.
[15] Hyon K. Choi,et al. Independent Impact of Gout on Mortality and Risk for Coronary Heart Disease , 2007, Circulation.
[16] S. Navarra,et al. Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: a randomized controlled trial. , 2004, Arthritis and rheumatism.
[17] L. Annemans,et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000–2005 , 2007, Annals of the rheumatic diseases.
[18] W. Bilker,et al. Gout epidemiology: results from the UK General Practice Research Database, 1990–1999 , 2005, Annals of the rheumatic diseases.
[19] R. Wortmann,et al. Management of Gout in Older Adults , 2007, Drugs & aging.
[20] Hyon K. Choi,et al. Pathogenesis of Gout , 2005, Annals of Internal Medicine.
[21] Chaoyang Li,et al. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. , 2007, Arthritis and rheumatism.
[22] P. Routledge,et al. Colchicine induced rhabdomyolysis , 2001, Postgraduate medical journal.
[23] Hyon K. Choi,et al. AMERICAN COLLEGE OF PHYSICIANS; AMERICAN PHYSIOLOGICAL SOCIETY. PATHOGENESIS OF GOUT , 2005 .
[24] P Netter,et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT) , 2006, Annals of the rheumatic diseases.
[25] G. Starkebaum,et al. Colchicine induced rhabdomyolysis. , 1997, The Journal of rheumatology.
[26] T. Cheng,et al. A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis. , 2004, Clinical therapeutics.
[27] C. Weinberg,et al. Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. , 1991, Annals of internal medicine.
[28] Hyon K. Choi,et al. Lifestyle and gout , 2008, Current opinion in rheumatology.
[29] M. Jolly,et al. Hyperuricemia and associated diseases. , 2006, Rheumatic diseases clinics of North America.
[30] T. Pope,et al. Gout: a clinical and radiologic review. , 2004, Radiologic clinics of North America.
[31] C K Yeung,et al. Fatal interaction between clarithromycin and colchicine in patients with renal insufficiency: a retrospective study. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[32] R. Bonnel,et al. Deaths associated with inappropriate intravenous colchicine administration. , 2002, The Journal of emergency medicine.
[33] R. Willburger,et al. Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout. , 2007, Rheumatology.
[34] W. Willett,et al. Alcohol intake and risk of incident gout in men: a prospective study , 2004, The Lancet.
[35] Hyon K. Choi. Epidemiology of crystal arthropathy. , 2006, Rheumatic diseases clinics of North America.
[36] S. Gabriel,et al. Epidemiology of gout: is the incidence rising? , 2002, The Journal of rheumatology.
[37] C. Wise. Crystal-associated arthritis in the elderly. , 2000, Rheumatic diseases clinics of North America.
[38] D. Mount,et al. Renal urate transport. , 2006, Rheumatic diseases clinics of North America.
[39] P. Macdonald,et al. Clinical trials in crystal arthropathy. , 2006, Rheumatic diseases clinics of North America.
[40] M. Doherty,et al. The changing epidemiology of gout , 2007, Nature Clinical Practice Rheumatology.
[41] N. Schlesinger. Diagnosis of gout: clinical, laboratory, and radiologic findings. , 2005, The American journal of managed care.
[42] G. Alaylı,et al. Acute Myopathy in a Patient with Concomitant Use of Pravastatin and Colchicine , 2005, The Annals of pharmacotherapy.
[43] R. Terkeltaub. Clinical practice. Gout. , 2003, The New England journal of medicine.
[44] S. Kong,et al. A literature review of the epidemiology and treatment of acute gout. , 2003, Clinical therapeutics.
[45] C. Torrance,et al. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. , 1992, The New England journal of medicine.
[46] D. Furst,et al. Gout and the risk of acute myocardial infarction. , 2006, Arthritis and rheumatism.
[47] W. Willett,et al. Coffee consumption and risk of incident gout in men: a prospective study. , 2007, Arthritis and rheumatism.
[48] C. Wise. Crystal-associated arthritis in the elderly. , 2005, Clinics in geriatric medicine.
[49] M. Underwood. Diagnosis and management of gout , 2006, BMJ : British Medical Journal.
[50] R. Burgos-Vargas,et al. Metabolic Syndrome and Ischemic Heart Disease in Gout , 2004, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[51] A. Romanowicz,et al. Effectiveness of etodolac ('Lodine') compared with naproxen in patients with acute gout. , 1991, Current medical research and opinion.
[52] M. Keith,et al. Updates in the management of gout. , 2007, The American journal of medicine.
[53] Hyon K. Choi,et al. Obesity, weight change, hypertension, diuretic use, and risk of gout in men: the health professionals follow-up study. , 2005, Archives of internal medicine.
[54] H. Christian,et al. Activation of melanocortin type 3 receptor as a molecular mechanism for adrenocorticotropic hormone efficacy in gouty arthritis. , 2002, Arthritis and rheumatism.
[55] P. Brooks,et al. Does colchicine work? The results of the first controlled study in acute gout. , 1987, Australian and New Zealand journal of medicine.
[56] D. Hunter,et al. Alcohol consumption as a trigger of recurrent gout attacks. , 2006, The American journal of medicine.
[57] J. Boice,et al. Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis , 2002, BMJ : British Medical Journal.
[58] Elizabeth W Karlson,et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. , 2004, The New England journal of medicine.
[59] F. Sivera,et al. Therapeutic advances in gout , 2007, Current opinion in rheumatology.
[60] M. A. Winblad,et al. Flurbiprofen in the treatment of acute gout. A comparison with indomethacin. , 1986, The American journal of medicine.